Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 14/20 | 0.65 |
| ▸ | PTGES | O14684 | 2/20 | 0.65 |
| ▸ | PNLIP | P16233 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.47 |
| ▸ | BCL9 | O00512 | 3/20 | 0.42 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rosmanol SCHEMBL13062163 | 1.00 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Epirosmanol SCHEMBL3272202 | 1.00 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Rosmanol SCHEMBL459610 | 1.00 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Rosmanol SCHEMBL28962181 | 1.00 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| SCHEMBL29385649 | 0.88 | FDPS (0.64) | FDPSPTGESPNLIPMEN1KMT2A | |
| SCHEMBL31238108 | 0.86 | FDPS (0.61) | FDPSPTGESPNLIPMEN1KMT2A | |
| Rosmanol SCHEMBL28178098 | 0.86 | FDPS (0.50) | FDPSPTGESPNLIPMEN1KMT2A | |
| Epiisorosmanol SCHEMBL29511557 | 0.84 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Isorosmanol SCHEMBL12574307 | 0.84 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Isorosmanol SCHEMBL13294492 | 0.84 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4518685-A1 | METHOD OF PREVENTING AND/OR INHIBITING THE OUTGROWTH, SPORULATION, GERMINATION OR TOXIN FORMATION OF CLOSTRIDIUM | Givaudan SA (CH) | 2025-03-12 | — | — | EP | claimed |
| EP-4514153-A1 | COMPOSITION AND METHOD FOR REDUCING THE AMOUNT OF ACRYLAMIDE IN FOOD | Givaudan SA (CH) | 2025-03-05 | — | — | EP | claimed |
| CN-119156145-A | Compositions and methods for reducing the amount of acrylamide in foods | 奇华顿股份有限公司 | 2024-12-17 | — | — | CN | claimed |
| US-12163004-B2 | Polymer composites | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-12-10 | — | — | US | claimed |
| WO-2023208753-A1 | COMPOSITION AND METHOD FOR REDUCING THE AMOUNT OF ACRYLAMIDE IN FOOD | GIVAUDAN SA (CH) | 2023-11-02 | — | — | WO | claimed |
| US-20230337668-A1 | COMPOSITION | GIVAUDAN SA (CH) | 2023-10-26 | — | — | US | claimed |
| CN-116600646-A | Preservative and antimicrobial compositions | 奇华顿股份有限公司 | 2023-08-15 | — | — | CN | claimed |
| EP-4213630-A2 | PRESERVATIVE AND ANTIMICROBIAL COMPOSITIONS | Givaudan SA (CH) | 2023-07-26 | — | — | EP | claimed |
| WO-2023021082-A1 | COMPOSITION | GIVAUDAN SA (CH) | 2023-02-23 | — | — | WO | claimed |
| EP-4021197-A1 | PET FOOD COMPOSITIONS | Hill's Pet Nutrition, Inc. (US) | 2022-07-06 | — | — | EP | claimed |
| WO-2022058343-A2 | COMPOSITION | GIVAUDAN SA (CH) | 2022-03-24 | — | — | WO | claimed |
| CN-122055354-A | Lipid compounds and related compositions and uses | 波西达治疗公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260123657-A1 | COMPOSITIONS AND METHODS FOR MASKING OFF-NOTES IN CONSUMABLES | GIVAUDAN SA (CH) | 2026-05-07 | — | — | US | disclosed |
| WO-2026087310-A1 | COMPOSITION, CONSUMABLE AND METHODS | GIVAUDAN SA (CH) | 2026-04-30 | — | — | WO | disclosed |
| EP-4204144-B1 | METHOD OF PRODUCING A METAL NANOPARTICLE | METALCHEMY LTD (GB) | 2026-03-18 | — | — | EP | disclosed |
| US-20220125730-A1 | METHOD OF MANUFACTURING AN ORALLY DISINTIGRATING TABLET | DEXCEL PHARMA TECHNOLOGIES LTD. (IL) | 2022-04-28 | — | — | US | disclosed |
| EP-3986160-A1 | EUTECTIC EXTRACTION OF SOLIDS | Givaudan SA (CH) | 2022-04-27 | — | — | EP | disclosed |
| WO-2022058343-A2 | COMPOSITION | GIVAUDAN SA (CH) | 2022-03-24 | — | — | WO | disclosed |
| US-11254781-B2 | Urethane-crosslinked biodegradable elastomers | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-02-22 | — | — | US | disclosed |
| WO-2022020464-A1 | MODIFIED RELEASE RAPIDLY DISINTEGRATING COMPOSITIONS OF PROTON PUMP INHIBITORS | ELLODI PHARMACEUTICALS, L.P. (US) | 2022-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260123657-A1 | COMPOSITIONS AND METHODS FOR MASKING OFF-NOTES IN CONSUMABLES | RBP4, RBP1, PROC | FDPS 1706/4885PTGES 1280/4885PNLIP 333/4885 |
| US-11254781-B2 | Urethane-crosslinked biodegradable elastomers | PUF60, XRCC5, XRCC6 | FDPS 1797/4885PTGES 731/4885PNLIP 3269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.